59
Participants
Start Date
July 21, 2015
Primary Completion Date
May 2, 2017
Study Completion Date
December 11, 2017
Regorafenib (Stivarga, BAY73-4506)
Regorafenib 160 mg orally once a day for 3 weeks of every 4 week cycle (i.e., 3 weeks on, 1 week off).
São Paulo
Lead Sponsor
Bayer
INDUSTRY